EMA Authorised: Omidria (ketorolac;phenylephrine) — Rayner Surgical (Ireland) Limited

View source ↗

Summary

The European Medicines Agency authorised Omidria, a fixed combination of ketorolac and phenylephrine, for use during lens implantation to reduce postoperative p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Omidria (phenylephrine/ketorolac intraocular solution)

Snippet

Status: Authorised. Therapeutic area: Lens Implantation, Intraocular;Pain, Postoperative. MAH: Rayner Surgical (Ireland) Limited. Decision date: 29/05/2024